FDA NDC Directory · JSON-LD · Markdown

Ondansetron

NDC 51655-008 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerNorthwind Health Company, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA078152
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsONDANSETRON (4 mg/1)
Marketing started20220808
Package count2

External sources

Source: openFDA. Public-domain (CC0).